Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2025)

Top pharmaceutical retailer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical retailer stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best drug store stocks to buy right now are:

111 (NASDAQ:YI) is the #1 top pharmaceutical retailer stock out of 8 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for 111 (NASDAQ:YI) is: Value: C, Growth: B, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: D.

111 (NASDAQ:YI) has a Due Diligence Score of 24, which is -1 points lower than the pharmaceutical retailer industry average of 25.

YI passed 8 out of 33 due diligence checks and has weak fundamentals. 111 has seen its stock lose -27.74% over the past year, overperforming other pharmaceutical retailer stocks by 13 percentage points.

High Tide (NASDAQ:HITI) is the #2 top pharmaceutical retailer stock out of 8 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for High Tide (NASDAQ:HITI) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: D, Financials: C, and AI: C.

High Tide (NASDAQ:HITI) has a Due Diligence Score of 37, which is 12 points higher than the pharmaceutical retailer industry average of 25.

HITI passed 12 out of 33 due diligence checks and has average fundamentals. High Tide has seen its stock return 7.44% over the past year, overperforming other pharmaceutical retailer stocks by 49 percentage points.

Wellgistics Health (NASDAQ:WGRX) is the #3 top pharmaceutical retailer stock out of 8 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Wellgistics Health (NASDAQ:WGRX) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: D, Financials: F, and AI: C.

Wellgistics Health (NASDAQ:WGRX) has a Due Diligence Score of 4, which is -21 points lower than the pharmaceutical retailer industry average of 25.

WGRX passed 1 out of 33 due diligence checks and has weak fundamentals.

50% of pharmaceutical retailer stocks rated by analysts are a hold right now. On average, analysts expect pharmaceutical retailer stocks to rise by 0.71% over the next year.

0% of pharmaceutical retailer stocks have a Zen Rating of A (Strong Buy), 0% of pharmaceutical retailer stocks are rated B (Buy), 100% are rated C (Hold), 0% are rated D (Sell), and 0% are rated F (Strong Sell).

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical retailer stocks right now are:

High Tide (NASDAQ:HITI) is the most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

High Tide has a valuation score of 29, which is 7 points higher than the pharmaceutical retailer industry average of 22. It passed 2 out of 7 valuation due diligence checks.

High Tide's stock has gained 7.44% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 49 percentage points.

111 (NASDAQ:YI) is the second most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

111 has a valuation score of 0, which is -22 points higher than the pharmaceutical retailer industry average of 22. It passed 0 out of 7 valuation due diligence checks.

111's stock has dropped -27.74% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 13 percentage points.

Petmed Express (NASDAQ:PETS) is the third most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Petmed Express has a valuation score of 29, which is 7 points higher than the pharmaceutical retailer industry average of 22. It passed 2 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -21.98% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 19 percentage points.

Pharmaceutical retailer stocks were down -0.09% in the last day, and down -0.03% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are down.